These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 12434589)

  • 1. [Pros and cons of methadone?].
    Lôo H; Laqueille X
    Rev Prat; 2002 Oct; 52(15):1629-30. PubMed ID: 12434589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Dogmatism on methadone].
    Waal H
    Tidsskr Nor Laegeforen; 1998 Oct; 118(25):3996. PubMed ID: 9830350
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating opioid dependency and coexistent chronic nonmalignant pain.
    Blondell RD; Ashrafioun L
    Am Fam Physician; 2008 Nov; 78(10):1132-3. PubMed ID: 19035061
    [No Abstract]   [Full Text] [Related]  

  • 4. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain.
    Brown R; Kraus C; Fleming M; Reddy S
    Postgrad Med J; 2004 Nov; 80(949):654-9. PubMed ID: 15537850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased assessment and monitoring needed for patients receiving methadone.
    Merlo LJ; Gold MS
    Am J Med; 2008 May; 121(5):e23; author repply e25. PubMed ID: 18456018
    [No Abstract]   [Full Text] [Related]  

  • 6. Methadone in the chronic pain patient with a substance use disorder.
    Reisfield GM; Friedman CK
    J Pain Palliat Care Pharmacother; 2012 Dec; 26(4):368-70. PubMed ID: 23216175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuropsychological functioning of opiate-dependent patients: a nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment.
    Loeber S; Kniest A; Diehl A; Mann K; Croissant B
    Am J Drug Alcohol Abuse; 2008; 34(5):584-93. PubMed ID: 18720267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Maintenance treatment for opiate dependence. Which should we deliver and how should we prescribe it?].
    Jacquiez O
    Ann Med Interne (Paris); 2003 Jun; 154 Spec No 1():S55-7. PubMed ID: 12910035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methadone maintenance expands inside federal prisons.
    Sibbald B
    CMAJ; 2002 Nov; 167(10):1154. PubMed ID: 12427715
    [No Abstract]   [Full Text] [Related]  

  • 10. New hot topics sections: 1. China's new march forward in addiction treatment: methadone for the masses. 2. Issues in formulating DSM V.
    Kosten TR; Gardner TJ
    Am J Drug Alcohol Abuse; 2008; 34(2):123-6. PubMed ID: 18293228
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical use of methadone.
    Layson-Wolf C; Goode JV; Small RE
    J Pain Palliat Care Pharmacother; 2002; 16(1):29-59. PubMed ID: 14650449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of opioid substitution therapy on alcohol metabolism.
    Clark NC; Dietze P; Lenné MG; Redman JR
    J Subst Abuse Treat; 2006 Apr; 30(3):191-6. PubMed ID: 16616162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Driving capacity of patients treated with methadone and slow-release oral morphine.
    Giacomuzzi SM; Ertl M; Vigl A; Riemer Y; Günther V; Kopp M; Pilsz W; Haaser W
    Addiction; 2005 Jul; 100(7):1027. PubMed ID: 15955021
    [No Abstract]   [Full Text] [Related]  

  • 14. Methadone treatment.
    Rashiq S
    CMAJ; 1999 Nov; 161(10):1241. PubMed ID: 10584081
    [No Abstract]   [Full Text] [Related]  

  • 15. [Evaluation of methadone dispensing in Belgium--study synopsis].
    Ledoux Y
    J Pharm Belg; 2004; 59(3):69-79. PubMed ID: 15553322
    [No Abstract]   [Full Text] [Related]  

  • 16. Methadone-associated QT prolongation and torsades de pointes. Dubrey and Groscott-Mason's patient was underttreated for her atrial fibrillation.
    Al-Sardar H
    Br J Hosp Med (Lond); 2007 Apr; 68(4):221; author reply 221. PubMed ID: 17469230
    [No Abstract]   [Full Text] [Related]  

  • 17. Opioid analgesics in the substance abuser: pros and cons.
    Ineck JR; Rule AM
    J Pain Palliat Care Pharmacother; 2006; 20(3):39-41. PubMed ID: 16931480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serious adverse events in the Australian National Evaluation of Pharmacotherapies for Opioid Dependence (NEPOD).
    Digiusto E; Shakeshaft A; Ritter A; O'Brien S; Mattick RP;
    Addiction; 2004 Apr; 99(4):450-60. PubMed ID: 15049745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors associated with the prescribing of buprenorphine or methadone for treatment of opiate dependence.
    Ridge G; Gossop M; Lintzeris N; Witton J; Strang J
    J Subst Abuse Treat; 2009 Jul; 37(1):95-100. PubMed ID: 19004598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug addiction from a psychodynamic perspective: methadone maintenance treatment (MMT) as transitional phenomena.
    Potik D; Adelson M; Schreiber S
    Psychol Psychother; 2007 Jun; 80(Pt 2):311-25. PubMed ID: 17535602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.